{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:09:23Z","timestamp":1762078163504,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL061744"],"award-info":[{"award-number":["HL061744"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008270","name":"Lantheus Medical Imaging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","award":["R01 HL71306"],"award-info":[{"award-number":["R01 HL71306"]}],"id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.amjcard.2009.02.046","type":"journal-article","created":{"date-parts":[[2009,5,14]],"date-time":"2009-05-14T04:25:38Z","timestamp":1242275138000},"page":"52-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Relation of Severe Coronary Artery Narrowing to Insulin or Thiazolidinedione Use in Patients With Type 2 Diabetes Mellitus (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Study)"],"prefix":"10.1016","volume":"104","author":[{"given":"Rodica","family":"Pop-Busui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Lombardero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Lavis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Forker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Korytkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burton E.","family":"Sobel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa L.Z.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl","key":"10.1016\/j.amjcard.2009.02.046_bib1","doi-asserted-by":"crossref","first-page":"9G","DOI":"10.1016\/j.amjcard.2006.02.023","article-title":"Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial","volume":"97","author":"Brooks","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2009.02.046_bib2","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ahj.2008.05.015","article-title":"Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the BARI 2D trial","volume":"156","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2009.02.046_bib3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1067\/mhj.2001.116481","article-title":"Validation of three myocardial jeopardy scores in a population-based cardiac catheterization cohort","volume":"142","author":"Graham","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2009.02.046_bib4","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/eurheartj\/ehm212","article-title":"Angiographic estimates of myocardium at risk during acute myocardial infarction: validation study using cardiac magnetic resonance imaging","volume":"28","author":"Ortiz-Perez","year":"2007","journal-title":"Eur Heart J"},{"issue":"suppl 1","key":"10.1016\/j.amjcard.2009.02.046_bib5","first-page":"S4","article-title":"Standards of medical care in diabetes\u20142007","volume":"30","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2009.02.046_bib6","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2337\/diacare.17.11.1281","article-title":"A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy","volume":"17","author":"Feldman","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2009.02.046_bib7","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s00125-006-0176-9","article-title":"Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin","volume":"49","author":"Evans","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.amjcard.2009.02.046_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000006909","article-title":"Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up","volume":"91","author":"Fisman","year":"1999","journal-title":"Cardiology"},{"key":"10.1016\/j.amjcard.2009.02.046_bib9","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.2337\/diacare.25.12.2244","article-title":"Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes","volume":"25","author":"Johnson","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2009.02.046_bib10","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/01.mjt.0000208276.65249.1b","article-title":"Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus","volume":"13","author":"Ravipati","year":"2006","journal-title":"Am J Ther"},{"key":"10.1016\/j.amjcard.2009.02.046_bib11","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S0002-9149(98)00157-X","article-title":"Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients","volume":"81","author":"Kornowski","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2009.02.046_bib12","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jacc.2005.03.074","article-title":"Atherothrombosis and high-risk plaque: part I: evolving concepts","volume":"46","author":"Fuster","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"suppl","key":"10.1016\/j.amjcard.2009.02.046_bib13","doi-asserted-by":"crossref","first-page":"3Q","DOI":"10.1016\/j.amjcard.2006.09.020","article-title":"Atherosclerosis: disease biology affecting the coronary vasculature","volume":"98","author":"Libby","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2009.02.046_bib14","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.amjcard.2007.10.020","article-title":"Comparison of intravascular ultrasound and angiographic assessment of coronary reference segment size in patients with type 2 diabetes mellitus","volume":"101","author":"Jensen","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2009.02.046_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jacc.2008.03.051","article-title":"Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials","volume":"52","author":"Nicholls","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2009.02.046_bib16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jdiacomp.2007.06.007","article-title":"Volumetric intravascular ultrasound imaging to illustrate the extent of coronary plaque burden in type 2 diabetic patients","volume":"21","author":"Schukro","year":"2007","journal-title":"J Diabetes Complications"},{"issue":"suppl 8A","key":"10.1016\/j.amjcard.2009.02.046_bib17","doi-asserted-by":"crossref","first-page":"99S","DOI":"10.1016\/j.amjmed.2003.09.016","article-title":"Endothelial function, inflammation, and prognosis in cardiovascular disease","volume":"115","author":"Gonzalez","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2009.02.046_bib18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1291\/hypres.30.387","article-title":"Blood pressure control and inflammatory markers in type 2 diabetic patients treated with pioglitazone or rosiglitazone and metformin","volume":"30","author":"Derosa","year":"2007","journal-title":"Hypertens Res"},{"key":"10.1016\/j.amjcard.2009.02.046_bib19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/01.CIR.0000055014.62083.05","article-title":"C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"issue":"suppl","key":"10.1016\/j.amjcard.2009.02.046_bib20","doi-asserted-by":"crossref","first-page":"27B","DOI":"10.1016\/j.amjcard.2006.11.004","article-title":"Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists","volume":"99","author":"Libby","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2009.02.046_bib21","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0140-6736(05)70804-7","article-title":"Endothelial inflammation in insulin resistance","volume":"365","author":"Sjoholm","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2009.02.046_bib22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1161\/01.HYP.0000144400.49062.6b","article-title":"Angiotensin II regulation of collagen type I expression in cardiac fibroblasts: modulation by PPAR-gamma ligand pioglitazone","volume":"44","author":"Chen","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2009.02.046_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1464-5491.2004.01155.x","article-title":"Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance","volume":"21","author":"Bennett","year":"2004","journal-title":"Diabet Med"},{"key":"10.1016\/j.amjcard.2009.02.046_bib24","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2337\/diacare.28.7.1547","article-title":"A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia","volume":"28","author":"Goldberg","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2009.02.046_bib25","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1001\/jama.296.21.joc60158","article-title":"Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial","volume":"296","author":"Mazzone","year":"2006","journal-title":"JAMA"},{"issue":"suppl","key":"10.1016\/j.amjcard.2009.02.046_bib26","first-page":"e1","article-title":"A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes","volume":"153","author":"Stocker","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2009.02.046_bib27","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/jama.299.13.1561","article-title":"Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial","volume":"299","author":"Nissen","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2009.02.046_bib28","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"N Engl J Med"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914909006687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914909006687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:01:11Z","timestamp":1762077671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914909006687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0002914909006687"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2009.02.046","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relation of Severe Coronary Artery Narrowing to Insulin or Thiazolidinedione Use in Patients With Type 2 Diabetes Mellitus (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Study)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2009.02.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}